Our group aims to 1) decipher the unresolved questions related to virus-driven carcinogenesis [in particular associated to human papillomavirus (HPV) infections] as well as 2) highlight novel immunotherapeutic targets/strategies.
Michael Herfs' team (Laboratory of Experimental Pathology, GIGA-Cancer) demonstrates that, by hijacking host DNA damage/repair mechanisms, human papillomaviruses (HPV) actively contribute to the elevated radiosensitivity of virus-related cancers.
Michael Herfs' team (Laboratory for Experimental Pathology, GIGA-Cancer) demonstrates that, by drastically inhibiting innate immunity, human papillomaviruses (HPV) promote the development of bacterial vaginosis.
Michael Herfs' team (Lab for Experimental Pathology, GIGA-Cancer) demonstrates the importance of blocking the oxidized form of this protein to reactivate anti-tumor immunity and improve the effectiveness of immune checkpoint inhibitors.
Michael Herfs
GIGA-Cancer, B23 (4th floor)
Avenue Hippocrate 13, 4000 Liege, Belgium
Tel: +32 4 366 42 82
